Université Claude Bernard Lyon 1 campus

Health Sciences

Master Santé publique – Methods for Drug Development and Evaluation (M2) at Université Claude Bernard Lyon 1

Université Claude Bernard Lyon 1, France

Programme overview

The main objective of the M2 MDDE specialization is to train professionals in Drug Development and Evaluation, focusing on pharmacological, pharmacokinetic and clinical efficacy-tolerance aspects. Today, the B3H and MDDE specialties are actively visiting engineering schools and the R&D departments of industrial groups, in order to: 1 - Recruit top-level students. 2 - Ensure optimum follow-up of job offers in these cutting-edge sectors.

Faculty: Faculté de Médecine Lyon Est  |  Duration: 4 semesters (2 years)  |  Study mode: full-time  |  Location: Villeurbanne, Auvergne-Rhône-Alpes, France

What you will study

Students use the literature to build mathematical models describing pharmacokinetics and pharmacodynamics, and analyse data at individual and population level.

Official programme page

Application information

Entry requirements

Subject to the admission jury; students of medicine, pharmacy, veterinary school and dentistry who validated 2 Human Biology research certificates or an M1 or equivalent.

Domestic applicants: EUR 255 a year (2026/2027). National registration fee (Master) 2026/2027 for EU/EEA students and others not subject to differentiated fees. Excludes CVEC. Source

International applicants: EUR 3,950 a year (2026/2027). Differentiated registration fee for non-EU/EEA students 2026/2027 (master); exemptions possible. Excludes CVEC. Source

Duration: 4 semesters (2 years)

Explore more study programmes

View all study programmes →

Ready to start your study abroad journey?

Book a free consultation with our expert counsellors and take the first step towards your dream university.

Copyrights © 2026 StudyMapped. All rights reserved.